This matters for how you talk to patients and readers about these medications
Two types of medications for ulcers and gastric reflux proton-pump inhibitors, such as omeprazole (Prilosec) and lansoprazole (Prevacid), and H2 blockers like cimetidine (Tagamet), famotidine (Pepcid), and ranitidine (Zantac) inhibit the release of stomach acid necessary to free dietary vitamin B12
issues: This can include nausea, vomiting, stomach cramps, bloating, constipation, and diarrhea
This widespread off-label use creates specific legal questions about: Whether patients received adequate warnings Whether doctors were properly informed of risks Whether marketing encouraged inappropriate use Wegovy (Weight Management Medication) FDA-Approved Use: Chronic weight management in adults with obesity (BMI 30) Chronic weight management in adults with overweight (BMI 27) who have weight-related conditions Dosing Schedule: Slower escalation schedule over 16-20 weeks Starting dose: 0.25 mg weekly Gradual increases: 0.5 mg 1.0 mg 1.7 mg Maximum dose: 2.4 mg weekly (higher than Ozempic) Intended Primary Effect: Weight loss Body weight reduction of 15%+ on average Additional Considerations: Typically requires obesity or overweight diagnosis May be covered by insurance for weight management Clinical trials specifically measured weight loss outcomes Critical Legal Distinctions Even though Ozempic and Wegovy are the same drug, in lawsuits your exact prescription matters significantly : 1
doi:10.1016/j.ejphar.2010.02.045 Lennon DL, Shrago ER, Madden M, Nagle FJ, Hanson P (1986) Dietary carnitine intake related to skeletal muscle and plasma carnitine concentrations in adult men and women
However, the vast majority of HDACi exhibit global inhibition of diverse HDACs isoforms
